Get started
ARROWHEAD PHARMACEUTICALS INC COM USD0.001ARROWHEAD PHARMACEUTICALS INC COM USD0.001ARROWHEAD PHARMACEUTICALS INC COM USD0.001

ARROWHEAD PHARMACEUTICALS INC COM USD0.001

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0HI3 chart


Full chart

0HI3 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.72 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.65 USD
Net income (FY)
‪−205.28 M‬ USD
Revenue (FY)
‪240.74 M‬ USD
Shares float
‪118.50 M‬
Beta (1Y)
1.54

Employees


Employees (FY)
525
Change (1Y)
+128 +32.24%
Revenue / Employee (1Y)
‪458.54 K‬ USD
Net income / Employee (1Y)
‪−391.00 K‬ USD

About Arrowhead Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher Richard Anzalone
Website
arrowheadpharma.com
Headquarters
Pasadena
Founded
1989
FIGI
BBG00JVRN7B1
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0HI3 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0HI3 is 21.86 USD — it has increased by 1.71% in the past 24 hours. Watch ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stocks are traded under the ticker 0HI3.
0HI3 stock has risen by 11.20% compared to the previous week, the month change is a 24.22% rise, over the last year ARROWHEAD PHARMACEUTICALS INC COM USD0.001 has showed a −20.68% decrease.
We've gathered analysts' opinions on ARROWHEAD PHARMACEUTICALS INC COM USD0.001 future price: according to them, 0HI3 price has a max estimate of 71.00 USD and a min estimate of 20.00 USD. Watch 0HI3 chart and read a more detailed ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock forecast: see what analysts think of ARROWHEAD PHARMACEUTICALS INC COM USD0.001 and suggest that you do with its stocks.
0HI3 reached its all-time high on Feb 10, 2021 with the price of 92.15 USD, and its all-time low was 5.16 USD and was reached on Feb 14, 2018. View more price dynamics on 0HI3 chart.
See other stocks reaching their highest and lowest prices.
0HI3 stock is 4.07% volatile and has beta coefficient of 1.54. Track ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock price on the chart and check out the list of the most volatile stocks — is ARROWHEAD PHARMACEUTICALS INC COM USD0.001 there?
Today ARROWHEAD PHARMACEUTICALS INC COM USD0.001 has the market capitalization of ‪2.72 B‬, it has decreased by −1.10% over the last week.
Yes, you can track ARROWHEAD PHARMACEUTICALS INC COM USD0.001 financials in yearly and quarterly reports right on TradingView.
ARROWHEAD PHARMACEUTICALS INC COM USD0.001 is going to release the next earnings report on Nov 26, 2024. Keep track of upcoming events with our Earnings Calendar.
0HI3 earnings for the last quarter are −1.38 USD per share, whereas the estimation was −0.53 USD resulting in a −160.91% surprise. The estimated earnings for the next quarter are −0.97 USD per share. See more details about ARROWHEAD PHARMACEUTICALS INC COM USD0.001 earnings.
ARROWHEAD PHARMACEUTICALS INC COM USD0.001 revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪52.87 M‬ USD. In the next quarter, revenue is expected to reach ‪55.07 M‬ USD.
0HI3 net income for the last quarter is ‪−170.79 M‬ USD, while the quarter before that showed ‪−125.30 M‬ USD of net income which accounts for −36.31% change. Track more ARROWHEAD PHARMACEUTICALS INC COM USD0.001 financial stats to get the full picture.
No, 0HI3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 525.00 employees. See our rating of the largest employees — is ARROWHEAD PHARMACEUTICALS INC COM USD0.001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARROWHEAD PHARMACEUTICALS INC COM USD0.001 EBITDA is ‪−529.78 M‬ USD, and current EBITDA margin is −79.97%. See more stats in ARROWHEAD PHARMACEUTICALS INC COM USD0.001 financial statements.
Like other stocks, 0HI3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARROWHEAD PHARMACEUTICALS INC COM USD0.001 technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARROWHEAD PHARMACEUTICALS INC COM USD0.001 stock shows the sell signal. See more of ARROWHEAD PHARMACEUTICALS INC COM USD0.001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.